Fulcrum Therapeutics, Inc. (FULC) › Net IncomeFulcrum Therapeutics, Inc. (FULC) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$32.59M2019: -$82.68M2020: -$70.82M2021: -$80.85M2022: -$109.87M2023: -$97.33M2024: -$9.72M2025: -$74.88M-$74.88M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$74.88M-670.0%2024-$9.72M+90.0%2023-$97.33M+11.4%2022-$109.87M-35.9%2021-$80.85M-14.2%2020-$70.82M+14.3%2019-$82.68M-153.7%2018-$32.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share